Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT07405645

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Led by University of Virginia · Updated on 2026-02-12

20

Participants Needed

6

Research Sites

202 weeks

Total Duration

On this page

Sponsors

U

University of Virginia

Lead Sponsor

F

Focused Ultrasound Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This phase 1 multi-site study investigates the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer and brachial cancer.

CONDITIONS

Official Title

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women between 18 and 85 years old
  • Diagnosed with head, neck, or brachial cancer including nasal cavity, sinuses, lips, mouth, salivary glands, throat, larynx, nasopharynx, skin, thyroid gland, eye, brachial plexus, upper lung apex, Pancoast tumors, lymphoma, or sarcoma
  • Craniofacial, cervical, or brachial pain related to cancer that is severe (worst pain score 5 or higher) and persistent for at least 2 months
  • Pain resistant to at least three prescription medications including weak and strong opioids
  • Duration of pain longer than 3 months
  • Contralateral mesencephalon target visible on MRI suitable for ExAblate Neuro device
  • Able and willing to give consent and attend all study visits
  • Able to communicate sensations during focused ultrasound treatment
Not Eligible

You will not qualify if you...

  • Idiopathic trigeminal neuralgia
  • Trigeminal neuropathic pain due to trauma, infection, or medical intervention
  • Post-herpetic neuralgia
  • Headache syndromes such as migraine or cluster headache
  • Temporomandibular joint syndrome
  • Atypical facial pain or somatoform disorder-related pain
  • Poor candidates as determined by cancer and palliative care clinicians, including limited life expectancy under 3 months
  • Unreliable self-reporting or active substance abuse
  • Active psychiatric illness including recent suicidal ideation, hospitalization, psychosis, or certain treatments for depression
  • Unstable heart conditions including recent heart attack, heart failure, or uncontrolled arrhythmias
  • Severe hypertension (diastolic blood pressure over 100 on medication)
  • Contraindications to MRI such as non-compatible implants or size limitations
  • Use of medications that increase bleeding risk within specific time frames
  • Unable to tolerate prolonged stationary supine position up to 4 hours
  • Participation in another pain management trial within the last 30 days
  • Bleeding risk due to coagulopathy or abnormal lab tests
  • Brain tumors or intracranial masses that block ultrasound except certain cerebral metastases
  • Any illness that prevents safe participation
  • Pregnancy or breastfeeding
  • Legal incapacity or limited legal capacity
  • Presence of deep brain stimulation implant
  • Skull density ratio less than 0.4
  • Recent hemorrhagic stroke or cerebrovascular event within past year with incomplete recovery
  • Primary pain not related to craniofacial or brachial neuropathic pain
  • High airway risk for procedure as assessed by anesthesia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

2

Weill Cornell Medicine

New York, New York, United States, 10065

Not Yet Recruiting

3

Oregon Health and Science University

Portland, Oregon, United States, 97239

Not Yet Recruiting

4

The University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Not Yet Recruiting

5

Baylor College of Medicine

Houston, Texas, United States, 77054

Not Yet Recruiting

6

University of Virginia

Charlottesville, Virginia, United States, 22903

Actively Recruiting

Loading map...

Research Team

W

William J Elias, MD

CONTACT

M

Marian Abdelmalek, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here